Charles Glaus
Bayer (United States)(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Nanoplatforms for cancer theranostics, Radiopharmaceutical Chemistry and Applications, Nanoparticle-Based Drug Delivery, Virus-based gene therapy research
Most-Cited Works
- → Gold Nanocages as Photothermal Transducers for Cancer Treatment(2010)690 cited
- → Inorganic nanoparticle-based contrast agents for molecular imaging(2010)242 cited
- → Gold Nanocages: A Novel Class of Multifunctional Nanomaterials for Theranostic Applications(2010)233 cited
- → In Vivo Evaluation of 64Cu-Labeled Magnetic Nanoparticles as a Dual-Modality PET/MR Imaging Agent(2010)210 cited
- → Local Delivery of OncoVEXmGM-CSF Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte–Associated Protein Blockade(2017)104 cited
- → A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses(2020)52 cited
- → Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture(2020)47 cited
- → Engineering NaV1.7 Inhibitory JzTx-V Peptides with a Potency and Basicity Profile Suitable for Antibody Conjugation To Enhance Pharmacokinetics(2019)16 cited
- Regional, kinetic [(18)F]FDG PET imaging of a unilateral Parkinsonian animal model.(2013)
- → Gene therapy for cross-correction of somatic organs and the CNS in mucopolysaccharidosis II in rodents and non-human primates(2023)10 cited